ATE266664T1 - Pyridinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen - Google Patents

Pyridinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen

Info

Publication number
ATE266664T1
ATE266664T1 AT00402359T AT00402359T ATE266664T1 AT E266664 T1 ATE266664 T1 AT E266664T1 AT 00402359 T AT00402359 T AT 00402359T AT 00402359 T AT00402359 T AT 00402359T AT E266664 T1 ATE266664 T1 AT E266664T1
Authority
AT
Austria
Prior art keywords
alkyl
pyridine derivatives
attached
production
pharmaceutical preparations
Prior art date
Application number
AT00402359T
Other languages
English (en)
Inventor
Jean-Louis Peglion
Aimee Dessinges
Christophe Poitevin
Mark Millan
Anne Dekeyne
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Application granted granted Critical
Publication of ATE266664T1 publication Critical patent/ATE266664T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Pulmonology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT00402359T 1999-08-27 2000-08-25 Pyridinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen ATE266664T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9910834A FR2797874B1 (fr) 1999-08-27 1999-08-27 Nouveaux derives de la pyridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
ATE266664T1 true ATE266664T1 (de) 2004-05-15

Family

ID=9549376

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00402359T ATE266664T1 (de) 1999-08-27 2000-08-25 Pyridinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen

Country Status (22)

Country Link
US (2) US6399616B1 (de)
EP (1) EP1078928B1 (de)
JP (1) JP3602780B2 (de)
KR (1) KR100450317B1 (de)
CN (1) CN1163495C (de)
AT (1) ATE266664T1 (de)
AU (1) AU765661B2 (de)
BR (1) BR0003848A (de)
CA (1) CA2317053A1 (de)
DE (1) DE60010596T2 (de)
DK (1) DK1078928T3 (de)
EA (1) EA004102B1 (de)
ES (1) ES2220359T3 (de)
FR (1) FR2797874B1 (de)
HU (1) HUP0003413A3 (de)
MX (1) MXPA00008241A (de)
NO (1) NO316651B1 (de)
NZ (1) NZ506560A (de)
PL (1) PL342178A1 (de)
PT (1) PT1078928E (de)
SI (1) SI1078928T1 (de)
ZA (1) ZA200004411B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2797874B1 (fr) * 1999-08-27 2002-03-29 Adir Nouveaux derives de la pyridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
DE10031391A1 (de) * 2000-07-03 2002-02-07 Knoll Ag Bicyclische Verbindungen und ihre Verwendung zur Prophylaxe und Therapie der zerebralen Ischämie
WO2002079189A2 (en) * 2001-03-29 2002-10-10 Tanabe Seiyaku Co., Ltd. Spiroisoquinoline compounds, methods for their preparation and intermediates
DE10217006A1 (de) * 2002-04-16 2003-11-06 Merck Patent Gmbh Substituierte Indole
EP2666772B1 (de) * 2002-12-20 2017-03-01 Basf Se Synthese von Aminen und Zwischenverbindungen für die Synthese davon
JP4559749B2 (ja) * 2004-02-16 2010-10-13 あすか製薬株式会社 ピペラジニルピリジン誘導体
JP4596792B2 (ja) * 2004-02-24 2010-12-15 あすか製薬株式会社 ５−ｈｔ１ａ作動作用と５−ｈｔ３拮抗作用を併有する薬剤
CN1922171B (zh) 2004-02-26 2012-10-17 Aska制药株式会社 嘧啶衍生物
DE102004023501A1 (de) * 2004-05-10 2005-12-01 Grünenthal GmbH Oxosubstituierte Cyclohexyl-1,4-diamin-Derivate
DE102004023506A1 (de) * 2004-05-10 2005-12-01 Grünenthal GmbH Kettenverlängerte substituierte Cyclohexyl-1,4-diamin-Derivate
DE102004023508A1 (de) * 2004-05-10 2005-12-08 Grünenthal GmbH Säurederivate substituierter Cyclohexyl-1,4-diamine
WO2006008192A1 (en) * 2004-07-23 2006-01-26 Bayer Cropscience Sa N-[2-(4-pyridinyl)ethyl]benzamide derivatives as fungicides
CA2585857A1 (en) 2004-11-26 2006-06-01 Janssen Pharmaceutica N.V. Isoxazoline-indole derivatives with an improved antipsychotic and anxiolytic activity
FR2909670B1 (fr) 2006-12-12 2010-07-30 Sanofi Aventis Derive fluore de quinoleine-2(1h)-one,son procede de preparation et son utilisation comme intermediaire de synthese
CN104337812B (zh) 2013-07-29 2018-09-14 广东东阳光药业有限公司 取代的杂芳基化合物及其使用方法和用途
CA2933466A1 (en) * 2013-12-13 2015-06-18 Takeda Pharmaceutical Company Limited Pyrrolo[3,2-c]pyridine derivatives as tlr inhibitors
US9968604B2 (en) 2015-04-16 2018-05-15 Chiesi Farmaceutici S.P.A. Chromene derivatives as phoshoinositide 3-kinases inhibitors
WO2016192657A1 (en) 2015-06-03 2016-12-08 Sunshine Lake Pharma Co., Ltd. Substituted piperazine compounds and methods of use and use thereof
CN106795160B (zh) * 2015-07-23 2019-04-19 广东东阳光药业有限公司 取代的吲哚化合物及其使用方法和用途
AU2022237901A1 (en) * 2021-03-19 2023-09-28 Centre National De La Recherche Scientifique Applications of biased ligands of the serotonin 5-ht7 receptor for the treatment of pain, multiple sclerosis and the control of thermoregulation.

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2761068A (en) * 1953-10-15 1956-08-28 Gen Electric Automatic pole figure recorder
FR2312498A1 (fr) * 1975-05-30 1976-12-24 Parcor Procede de preparation de la thieno (3,2-c) pyridine et de derives de celle-ci
FR2395271A1 (fr) * 1977-06-21 1979-01-19 Parcor Procede de preparation de thieno (2,3-c) et thieno (3,2-c) pyridines
KR830003481A (ko) * 1980-09-22 1983-06-20 미야다께 도꾸지로 6-플루오로-1,8-나프티리딘 유도체의 제조방법
AU553415B2 (en) * 1983-09-19 1986-07-17 Abbott Japan Co., Ltd. 6-fluoro-1-4-dihydro-4-oxo-7-substituted piperazinyl- quinoline-3-carboxylic acids
CA1278792C (en) * 1985-05-06 1991-01-08 Joseph P. Yevich Antipsychotic fused-ring pyridinylpiperazine derivatives
US5001130A (en) * 1988-02-18 1991-03-19 Bristol-Myers Company Psychotropic heterobicycloalkylpiperazine derivatives
JP2815126B2 (ja) * 1990-08-31 1998-10-27 日清製粉株式会社 ピリジンカルボン酸アミド誘導体
US5681954A (en) * 1993-05-14 1997-10-28 Daiichi Pharmaceutical Co., Ltd. Piperazine derivatives
US5300498A (en) * 1993-06-04 1994-04-05 Hoechst-Roussel Pharmaceuticals Incorporated 6-piperazinyl-1H-pyrazolo[3,4-b]pyridine-3-carboxylic acids, esters, amides and related compounds
FR2721800B1 (fr) * 1994-07-01 1997-12-26 Roussel Uclaf Nouveaux concentres emulsionnables renfermant un u plussieurs pesticides
AU2927495A (en) * 1994-07-06 1996-01-25 Quest International B.V. Use of dibutyl malate as insect attractant
DE4430593C2 (de) * 1994-08-20 1999-01-14 Max Delbrueck Centrum Verfahren zur Herstellung von Liposomal verkapseltem Taxol
FR2738823B1 (fr) * 1995-09-15 1997-10-31 Synthelabo Derives de 3-(omega-(4-(thieno(3,2-c)pyridin-4-yl)piperazin- 1-yl)alkyl)-3,4-dihydroquinolein-2(1h)-one,leur preparation et leur application en therapeutique
DE69605430T2 (de) * 1995-09-15 2000-07-13 Sanofi-Synthelabo, Paris Chinolin-2-on derivate als serotonin antagonisten
FR2761071B1 (fr) * 1997-03-20 1999-12-03 Synthelabo Derives de quinolein-2(1h)-one et de dihydroquinolein-2(1h)- one, leur preparation et leur application en therapeutique
FR2761068B1 (fr) * 1997-03-20 1999-04-23 Synthelabo Derives de piperazin-4-ylthieno[3,2-c]pyridin-4-yl-2- carboxamide, leur preparation et leur application en therapeutique
EP1020445B1 (de) * 1997-10-02 2008-08-13 Eisai R&D Management Co., Ltd. Kondensierte pyridinderivate
FR2797874B1 (fr) * 1999-08-27 2002-03-29 Adir Nouveaux derives de la pyridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
KR100450317B1 (ko) 2004-09-30
DE60010596D1 (de) 2004-06-17
CA2317053A1 (fr) 2001-02-27
DK1078928T3 (da) 2004-09-13
BR0003848A (pt) 2001-04-03
JP3602780B2 (ja) 2004-12-15
KR20010050228A (ko) 2001-06-15
EP1078928A1 (de) 2001-02-28
PL342178A1 (en) 2001-03-12
CN1163495C (zh) 2004-08-25
US20020161228A1 (en) 2002-10-31
ES2220359T3 (es) 2004-12-16
FR2797874B1 (fr) 2002-03-29
FR2797874A1 (fr) 2001-03-02
AU765661B2 (en) 2003-09-25
NZ506560A (en) 2001-06-29
NO20004295L (no) 2001-02-28
HK1034250A1 (en) 2001-10-19
PT1078928E (pt) 2004-09-30
CN1286255A (zh) 2001-03-07
HUP0003413A2 (hu) 2001-07-30
ZA200004411B (en) 2001-02-28
HUP0003413A3 (en) 2003-11-28
JP2001097978A (ja) 2001-04-10
EA200000792A3 (ru) 2001-06-25
US6486171B2 (en) 2002-11-26
NO20004295D0 (no) 2000-08-28
EA200000792A2 (ru) 2001-04-23
SI1078928T1 (en) 2004-08-31
NO316651B1 (no) 2004-03-22
DE60010596T2 (de) 2005-05-19
HU0003413D0 (en) 2000-08-25
EP1078928B1 (de) 2004-05-12
MXPA00008241A (es) 2002-08-20
US6399616B1 (en) 2002-06-04
AU5364200A (en) 2001-03-01
EA004102B1 (ru) 2003-12-25

Similar Documents

Publication Publication Date Title
ATE266664T1 (de) Pyridinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
FR2654104B1 (fr) Nouveaux derives du 1,2-benzisoxazole, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
IE782493L (en) Phosphonoformic acid derivatives
DE69100079D1 (de) Naphthalin-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
CY1110904T1 (el) Φαρμακευτικως ενεργα παραγωγα βενζοσουλφοναμιδιου ως αναστολεις πρωτεϊνικων κινασων jun
PT867436E (pt) Derivados de n-aril-piperidina e sua utilizacao como ligandos do receptor 5-ht1b
ATE105556T1 (de) Benzopyranverbindungen, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen.
EA200100090A2 (ru) Новые пиперидин-4-сульфонамидные производные, способ их получения и содержащие их фармацевтические композиции
ATE103921T1 (de) 1-oxa-2-oxo-8-azaspiro(4,5>decan-derivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen daraus.
DE60012287D1 (de) 9-(3,5-dimethoxyphenyl)-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphto[2,3-d][1,3]dioxol-6(5aH)-on - Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
EP0383318A3 (de) Aralkylamin-Verbindungen
ATE43575T1 (de) (4.2.0>-bicyclooctanderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
ATE216392T1 (de) 7-oxo-2,3,7,14-tetrahydro-1h-benzo(b)pyrano(3,2 h)acridincarboxylatderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
DE69702955D1 (de) Bis-Imide Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitung
DE69611594D1 (de) Tetrazyclisch 1,4-Oxazinverbindungen, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
ATE102204T1 (de) 2-oxo-1-oxa-8-azaspiro(4,5>decanderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE433439T1 (de) Anthranyl-derivate mit anti-cholecystokinin- aktivität (anti-cck-1) verfahren zu deren herstellung und deren pharmazeutische anwendung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1078928

Country of ref document: EP

REN Ceased due to non-payment of the annual fee